BioPoly engages in the research, design, and manufacture of orthopedic devices for use in the sports medicine, orthopedics, and spinal markets. It provides a treatment option for painful cartilage lesions between the extremes of biological solutions and total joint replacement. It offers BioPoly RS Knee System, a femoral condyle partial resurfacing device that is implanted utilizing a reusable instrument kit; and BioPoly-RS Partial Resurfacing Knee Implant, a long term surgically invasive device for the replacement of focal osteochondral defects in the knee ranging from 0.8-3.1 sq. cm.
BioPoly was formerly known as BioPoly RS. The company was incorporated in 2007 and is based in Fort Wayne, Indiana. The company operates as a subsidiary of Schwartz Biomedical.